AGP Executive Report
Last update: 3 hours agoPublic Health: WHO says a US-funded vaccine trial in Guinea-Bissau was cancelled over ethical concerns: it would have withheld a hepatitis B vaccine proven to protect newborns. Nearly one in five people in the country has hepatitis B, and officials are considering adding the birth-dose vaccine to routine immunisation in early 2027, ahead of the planned 2028 rollout. Electricity Access: An ECOWAS project has brought electricity to nearly 500,000 people in 490 localities across Guinea-Bissau, The Gambia and Mali. The $225 million programme is due to close at the end of 2026, with officials stressing that lasting household connections matter more than infrastructure completed. Land Disputes: In eastern Guinea-Bissau, local mediators are helping farmers and herders resolve conflicts over damaged crops and livestock before disputes escalate. Citizenship Rules: Portugal’s new law lets citizens of Portuguese-speaking countries, including Guinea-Bissau, apply for citizenship after seven years of residency, compared with 10 years for many other nationalities. It also removes a rule that counted time waiting for a residence permit.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
